David Engelmann

Rostock, MV 18057, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.

LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.

Journal: Theranostics

Published: January 21, 2020

Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers.

Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers.

Journal: Theranostics

Published: August 28, 2018

DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.

DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.

Journal: Cancer letters

Published: August 15, 2018

MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.

MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.

Journal: Molecular cancer

Published: August 04, 2016

Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures.

Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures.

Journal: Nature communications

Published: June 10, 2016

Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient Outcome.

Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient Outcome.

Journal: The Journal of urology

Published: January 29, 2016

Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.

Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.

Journal: Nucleic acids research

Published: March 13, 2015

Comprehensive genomic profiles of small cell lung cancer.

Comprehensive genomic profiles of small cell lung cancer.

Journal: Nature

Published: January 15, 2015

Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progression.

Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progression.

Journal: Science signaling

Published: October 02, 2014

A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Journal: Oncogene

Published: August 08, 2014

E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.

E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.

Journal: Journal of molecular cell biology

Published: September 10, 2013

DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.

DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.

Journal: Cancer cell

Published: March 12, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026